Gossamer Bio, Inc. (GOSS) vs Fractyl Health, Inc. (GUTS)

A side-by-side comparison of Gossamer Bio, Inc. and Fractyl Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Gossamer Bio, Inc. logo
GOSS
Gossamer Bio, Inc.
$65M
$10.67HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
Fractyl Health, Inc. logo
GUTS
Fractyl Health, Inc.
$60M
$4.54HealthcareDelayed quote: Oct 6, 2026, 3:33 PM EDT

Total return — GOSS vs GUTS

growth of $100 · dividends reinvested · last 3y
GOSS -84.0% (-45.7%/yr)GUTS -97.0% (-69.1%/yr)GOSS compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020252026$16$3
GOSS GUTS

GOSS vs GUTS: by the numbers

  • •GOSS is the larger company ($65M vs $60M market cap).
  • •Both run net losses; GUTS's is the smaller (0.00% vs -235.00% net margin).

Metrics side by side

Valuation

MetricGOSSGUTS
P/S ratio1.22N/A

Profitability

MetricGOSSGUTS
Gross margin99.56%0.00%
Operating margin-336.81%0.00%
Net margin-235.00%0.00%
ROICN/A-129.67%

Growth (annualized)

MetricGOSSGUTS
Total return CAGR (5Y)-59.51%N/A

Go deeper

Full GOSS analysisFull GUTS analysisInteractive comparison tool

Dig into the metrics

Gossamer Bio ROEFractyl Health ROEGossamer Bio operating marginFractyl Health operating marginGossamer Bio revenue growthFractyl Health revenue growthGossamer Bio free cash flowFractyl Health free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.